Alpha Tau Medical

company

About

Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT for the treatment of solid cancer tumors.

  • 51 - 100

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$92M
Industries
Health Care,Medical Device
Founded date
Jan 1, 2016
Number Of Employee
51 - 100
Operating Status
Active

Alpha Tau Medical is an Israeli medical device company that focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.

Since then, numerous preclinical trials have found the technology to be effective and safe for various indications and anatomic areas.

The findings were published in 12 papers in peer-reviewed scientific journals. Today, the company is running its first clinical trial with very promising preliminary results.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$151.70M
Alpha Tau Medical has raised a total of $151.70M in funding over 2 rounds. Their latest funding was raised on Mar 8, 2022 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 8, 2022 Post-IPO Equity $92M 1 Detail
Jun 4, 2020 Series B $26M 1 OurCrowd Detail
Sep 5, 2018 Series A $33.70M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Alpha Tau Medical is funded by 1 investors. OurCrowd are the most recent investors.
Investor Name Lead Investor Funding Round
OurCrowd Post-IPO Equity